Skip to content

Author

Wei-Ling Chang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Return-to-Play Outcomes After Primary Ulnar Collateral Ligament Reconstruction Vary Substantially Depending on Return Criteria: A Systematic Review Stratified by Competition Level.

PURPOSE To determine how return definitions influence return to play (RTP), return to the same level of play (RTSP), advancement rates, and return timelines after primary ulnar collateral ligament reconstruction (UCLR) in baseball pitchers across levels of competition. METHODS Following the Preferred Reporting Items...

Hung-Yu Chen, W. Chang, Kun-Hui Chen et al. · 0 citations
Open access Sep 2026

Deconvolution of the mechanisms of T cell drug response in multiple myeloma induction therapy

Lenalidomide (Revlimid™), bortezomib (Velcade™), and dexamethasone, are used alone or in combination (RVd therapy) as first-line therapies for hematologic malignancies including the plasma cell dyscrasia, Multiple Myeloma (MM). The effects of RVd treatment on tumor cells have been documented, but little is known about...

Lucas T. Graybuck, L. Okada, Wei-Ling Chang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.